Monday, November 7, 2011 - Actos is a diabetes drug that has been linked to bladder cancer by both the FDA and multiple European pharmaceutical regulatory agencies. The attorneys of The Onder Law Firm are currently investigating Actos bladder cancer claims in which patients developed bladder cancer after taking Actos. The Onder Law Firm also handled Avandia lawsuits, another diabetes drug which was linked to increased risk of heart attack and stroke.
The first FDA Actos bladder cancer announcement occurred in September of 2010 and was updated June 15, 1999. The second Actos bladder cancer FDA Safety Communication warned Actos users that the risk of developing bladder cancer could increase after just one year of Actos use.
Actos was approved by the FDA in 1999 to control blood sugar in adults with Type 2 diabetes. The drug is currently in the middle of a ten-year study to further understand the increased risk of bladder cancer it may pose. Actos is manufactured by Takeda Pharmaceuticals, Inc., the largest pharmaceutical firm in Japan.
The Onder Law Firm, a prominent national law firm with a long history of representing clients harmed by dangerous drugs and defective medical devices, is offering a free, no-obligation Actos bladder cancer claim review to families of persons whom have been diagnosed with bladder cancer after using Actos. The Onder Law Firm‘s Actos bladder cancer lawyers are handling all Actos bladder cancer lawsuits on a contingency basis. The law firm has created an Actos bladder cancer website with information about both Actos and bladder cancer litigation.